Advertisement
To listen to the audio web cast of the presentation during the event,please visit: www.nxstage.com and click on 'Investor Information'. A replaywill be available beginning September 7, 2007 for 30 days.
Advertisement
Forward-Looking Statements:
This release contains "forward-looking statements" within the meaning ofthe Private Securities Litigation Reform Act of 1995. All statements containedin this release that are not clearly historical in nature are forward-looking,and the words "anticipate," "believe," "expect," "estimate," "plan," andsimilar expressions are generally intended to identify forward-lookingstatements. Examples of these forward-looking statements include statements asto Mr. Burbank's plans to present at the Thomas Weisel Partners HealthcareConference. NxStage specifically disclaims any obligation to update theseforward-looking statements. These forward-looking statements should not berelied upon as representing NxStage's expectations or beliefs as of any datesubsequent to the date of this press release.
About NxStage Medical:
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company,headquartered in Lawrence, Massachusetts, USA, that develops, manufactures andmarkets innovative dialysis systems for the treatment of end-stage renaldisease, or ESRD, and acute kidney failure. For more information on NxStageand its products, please visit the company's website at www.nxstage.com.
SOURCE NxStage Medical, Inc.
